Phenoconversion of CYP2C9 in epilepsy limits the predictive value of CYP2C9 genotype in optimizing valproate therapy
出版年份 2015 全文链接
标题
Phenoconversion of CYP2C9 in epilepsy limits the predictive value of CYP2C9 genotype in optimizing valproate therapy
作者
关键词
-
出版物
Personalized Medicine
Volume 12, Issue 3, Pages 199-207
出版商
Future Medicine Ltd
发表日期
2015-06-05
DOI
10.2217/pme.14.82
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Addressing phenoconversion: the Achilles' heel of personalized medicine
- (2015) Rashmi R. Shah et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- CYP2C19 genotype–phenotype discordance in patients with multiple myeloma leads to an acquired loss of drug-metabolising activity
- (2014) K. E. Burns et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Challenges in CYP2D6 Phenotype Assignment from Genotype Data: A Critical Assessment and Call for Standardization
- (2014) J. Hicks et al. CURRENT DRUG METABOLISM
- Adverse drug reactions induced by valproic acid
- (2013) Radu M. Nanau et al. CLINICAL BIOCHEMISTRY
- Valproic acid pathway
- (2013) Yogita Ghodke-Puranik et al. Pharmacogenetics and Genomics
- Interleukin-6, interleukin-1 beta and interleukin-1 receptor antagonist levels in epileptic seizures
- (2013) Irem Fatma Uludag et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Effects of UGT1A6, UGT2B7, and CYP2C9 Genotypes on Plasma Concentrations of Valproic Acid in Chinese Children with Epilepsy
- (2012) Yingjie Guo et al. Drug Metabolism and Pharmacokinetics
- A meta-analysis of pro-inflammatory cytokines in the plasma of epileptic patients with recent seizure
- (2012) Nian Yu et al. NEUROSCIENCE LETTERS
- Population Differences in Major Functional Polymorphisms of Pharmacokinetics/pharmacodynamics-related Genes in Eastern Asians and Europeans: Implications in the Clinical Trials for Novel Drug Development
- (2011) Kouichi Kurose et al. Drug Metabolism and Pharmacokinetics
- LC–MS/MS method for simultaneous determination of valproic acid and major metabolites in human plasma
- (2011) Shouhong Gao et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- The influence of cytochrome oxidase CYP2A6, CYP2B6, and CYP2C9 polymorphisms on the plasma concentrations of valproic acid in epileptic patients
- (2010) Lan Tan et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Variability in drug metabolizing enzyme activity in HIV-infected patients
- (2010) Amanda E. Jones et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Molecular and Therapeutic Potential and Toxicity of Valproic Acid
- (2010) Sébastien Chateauvieux et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Influence of CYP2C9 polymorphism on metabolism of valproate and its hepatotoxin metabolite in Iranian patients
- (2010) Noushin Amini-Shirazi et al. TOXICOLOGY MECHANISMS AND METHODS
- Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation
- (2008) Ulrich M. Zanger et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- CYP2C19 pharmacogenetics in advanced cancer: compromised function independent of genotype
- (2008) N A Helsby et al. BRITISH JOURNAL OF CANCER
- Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: A review
- (2008) M. F. B. Silva et al. JOURNAL OF INHERITED METABOLIC DISEASE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now